Clinical trials
Myotonic Dystrophy trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 8 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 3 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| PepGen Inc | 3 |
| AMO Pharma Limited | 2 |
| Avidity Biosciences, Inc. | 2 |
| Laval University | 2 |
| McMaster University | 2 |
| Université de Sherbrooke | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Virginia Commonwealth University | 2 |
| ARTHEx Biotech S.L. | 1 |
| Cynthia Gagnon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myotonic Dystrophy | 27 |
| Myotonic Disorders | 6 |
| Muscular Diseases | 5 |
| Muscular Dystrophies | 5 |
| Neuromuscular Diseases | 5 |
| Genetic Diseases, Inborn | 4 |
| Heredodegenerative Disorders, Nervous System | 4 |
| Muscular Disorders, Atrophic | 4 |
| Musculoskeletal Diseases | 4 |
| Myotonia | 4 |
Trials
Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.